Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013		Mar. 31, 2012
OPERATING ACTIVITIES:
Net (loss) income	$ (207,056)		$ 5,053
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,781		7,430
Amortization and write-off of debt issuance costs	3,331		3,686
Provision for doubtful accounts	1,007		2,262
Equity-based compensation expense	1,813		1,631
Windfall tax benefits associated with equity-based compensation	(72)		0
Goodwill and other long-lived asset impairment	224,320	[1]	0
Deferred income tax (benefit) expense	(9,360)		6,531
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(4,855)		(24,441)
Prepaid expenses and other current assets	(162)		(10,347)
Accounts payable	(193)		3,330
Payroll and related taxes	(10,977)		(9,348)
Deferred revenue	2,376		5,683
Medicare liabilities	210		1,487
Obligations under insurance programs	(1,991)		1,622
Accrued nursing home costs	602		1,824
Other accrued expenses	(25,285)		(36,191)
Other, net	951		5,083
Net cash used in operating activities	(20,560)		(34,705)
INVESTING ACTIVITIES:
Purchase of fixed assets	(2,698)		(3,793)
Net cash used in investing activities	(2,698)		(3,793)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	992		705
Windfall tax benefits associated with equity-based compensation	72		0
Repayment of long-term debt	(25,000)		(50,000)
Debt issuance costs	0		(4,125)
Other	(263)		(232)
Net cash used in financing activities	(24,199)		(53,652)
Net change in cash and cash equivalents	(47,457)		(92,150)
Cash and cash equivalents at beginning of period	207,052		164,912
Cash and cash equivalents at end of period	159,595		72,762
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	28,728		27,776
Income taxes paid	$ 194		$ 247

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 7.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million , respectively, as a result of the impairment.